rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MRVI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Maravai LifeSciences at Stifel 2026 Healthcare Conference: growth broadens
      Nov 12Investing.comMRVISF
      KeyBanc upgrades Maravai LifeSciences stock rating on cost cuts
      Nov 12Investing.comMRVI
      Why Maravai LifeSciences Holdings (MRVI) Is Up After Raising Revenue Guidance
      Nov 6Yahoo FinanceMRVI
      Maravai LifeSciences Holdings, Inc. Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinanceMRVI
      What Maravai LifeSciences (MRVI) Said on Its Q3 Earnings Call
      Nov 5Yahoo FinanceMRVI
      Maravai LifeSciences Q3 2026 Earnings Call Transcript
      Nov 4BenzingaMRVI
      Maravai LifeSciences Reports Third Quarter 2026 Financial Results

      SAN DIEGO, November 04, 2026--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2026, together with other business updates.

      Nov 4Yahoo FinanceMRVI
      Maravai LifeSciences Announces November 2026 Investor Conference Schedule
      Oct 29Yahoo FinanceMRVI
      Is Maravai LifeSciences Holdings (MRVI) Priced Too Highly For Its Sales?
      Oct 27Yahoo FinanceMRVI
      Maravai LifeSciences (MRVI) Stock Gets Fair Value Boost On mRNA And CleanCap Optimism
      Oct 17Yahoo FinanceMRVI
      Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
      Oct 14Yahoo FinanceMRVI
      Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call - Maravai LifeSciences (NASDAQ:MRVI)

      Maravai LifeSciences (NASDAQ:MRVI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by

      Oct 13BenzingaMRVI
      TD Cowen initiates Maravai LifeSciences stock with buy rating
      Oct 5Investing.comMRVI
      TD Cowen Initiates Maravai Lifesciences at Buy With $9 Price Target
      Oct 5Yahoo FinanceMRVI
      What Is Maravai’s (MRVI) Comeback Really Worth to Investors?

      Maravai LifeSciences (NASDAQ:MRVI) enters 2026 at a strategic inflection point, balancing its post-pandemic operational transition against a core business model rooted in high-margin nucleic acid production and bioprocess impurity testing. With a market capitalization hovering near $2 billion against full-year revenue guidance of $205 million to $215 million, the company carries a structured balance sheet […]

      Oct 4Yahoo FinanceMRVI
      Maravai's TriLink Gets New China Patent for CleanCap Technology
      Sep 29Yahoo FinanceMRVI
      Is Maravai LifeSciences Holdings (MRVI) Cheap If Cash Flow Recovers?

      Maravai LifeSciences Holdings has seen its share price swing sharply in recent years, which raises a straightforward question for anyone looking at the stock today. Is the current US$7.65 price supported by the cash flows the business can generate over time, based on a Discounted Cash Flow (DCF) view of its intrinsic value? The stock has delivered a 171.3% return over the past year, which puts real pressure on the question of whether that move is fully backed by the cash the business is...

      Sep 25Yahoo FinanceMRVI
      Maravai LifeSciences Holdings (MRVI) Rebounded Sharply, Is The Upside Already Priced In?

      Maravai LifeSciences Holdings (MRVI) has been drawing attention after recent share price swings, with the stock closing at US$7.37 on 24 September 2026. Investors are weighing mixed return patterns across different holding periods. Recent trading in Maravai LifeSciences Holdings has been choppy, with a 7-day share price return of 7.75% but a 30-day move that is down 12.57%, while the 90-day gain of 20.42% and year to date share price return of 116.76% signal momentum that has cooled recently...

      Sep 24Yahoo FinanceMRVI
      Analysts Are Bullish on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Thermo Fisher (TMO)

      Detailed price information for Thermo Fisher Scientific (TMO-N) from The Globe and Mail including charting and trades.

      Sep 17The Globe and MailCOGTMRVI
      Maravai Lifesciences Holdings (MRVI) Receives a New Rating from UBS

      Detailed price information for Maravai Lifesciences Holdings Inc Cl A (MRVI-Q) from The Globe and Mail including charting and trades.

      Sep 10The Globe and MailMRVI
      UBS reiterates Maravai LifeSciences stock Neutral rating at $8 target
      Sep 9Investing.comMRVI
      UBS Adjusts Maravai Lifesciences Price Target to $8 From $2.50, Maintains Neutral Rating

      Maravai Lifesciences Holdings (MRVI) has an average rating of overweight and mean price target of $5

      Sep 9Yahoo FinanceMRVI
      Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel (MRVI)
      Sep 2Seeking AlphaMRVI

      This is the newest page. Registered accounts read further back.